Protective role of clusterin in preserving endothelial function in AL amyloidosis

Atherosclerosis. 2012 Nov;225(1):220-3. doi: 10.1016/j.atherosclerosis.2012.08.028. Epub 2012 Sep 1.

Abstract

Misfolded immunoglobulin light chain proteins (LC) in light chain amyloidosis (AL) are toxic to vascular tissues. We tested the hypothesis that chaperone protein clusterin preserves endothelial function and cell survival during LC exposure.

Methods: LC (20 μg/mL) were given to human aortic endothelial cells (EC) for 24-h and clusterin protein/gene expression and secretion were measured. DNA fragmentation was measured with/without recombinant clusterin (Clu, 300 ng/mL). Adipose arterioles (non-AL subjects) were tested for dilator responses to acetylcholine/papaverine at baseline and after 1-h of LC ± Clu.

Results: LC reduced EC clusterin secretion, protein and gene expression while increasing DNA fragmentation. Clu attenuated LC-induced DNA fragmentation and restored dilator response to acetylcholine (logEC50: control -7.05 ± 0.2, LC + Clu -6.53 ± 0.4, LC -4.28 ± 0.7, p < 0.05 versus control, LC + Clu).

Conclusions: LC induced endothelial cell death and dysfunction while reducing clusterin protein/gene expression and secretion. Exogenous clusterin attenuated LC toxicity. This represents a new pathobiologic mechanism and therapeutic target for AL amyloidosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloidosis / physiopathology*
  • Arterioles / physiopathology
  • Cell Death / drug effects
  • Clusterin / biosynthesis
  • Clusterin / physiology*
  • DNA Fragmentation / drug effects
  • Endothelial Cells / drug effects
  • Endothelial Cells / physiology*
  • Female
  • Humans
  • Immunoglobulin Light Chains* / metabolism
  • Immunoglobulin Light Chains* / pharmacology
  • Male
  • Middle Aged
  • Vasodilation / drug effects

Substances

  • Clusterin
  • Immunoglobulin Light Chains